Chiang A, Loblaw A, Jethava V, Sethukavalan P, Zhang L, Vesprini D, et al. Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer. CUAJ [Internet]. 2013 Dec. 5 [cited 2026 May 4];7(11-12):450-3. Available from: https://cuaj.ca/index.php/journal/article/view/262